These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 38950936)

  • 1. Promises and risks of opportunistic screening for cardiovascular disease.
    Arbab-Zadeh A
    J Cardiovasc Comput Tomogr; 2024; 18(4):423. PubMed ID: 38950936
    [No Abstract]   [Full Text] [Related]  

  • 2. Advanced cardiac imaging, machine learning, and heart age for cardiovascular risk stratification.
    Siontis GC; Patel CJ
    Int J Cardiovasc Imaging; 2024 Jul; 40(7):1605-1606. PubMed ID: 38613603
    [No Abstract]   [Full Text] [Related]  

  • 3. Calcification vs Inflammation: The Modern Toolkit for Cardiovascular Risk Assessment.
    Antoniades C; Chan K
    JACC Cardiovasc Imaging; 2024 Oct; 17(10):1225-1228. PubMed ID: 39384268
    [No Abstract]   [Full Text] [Related]  

  • 4. CAC Density and Cardiovascular Risk: Is Less Really More?
    Villines TC; Javaid A
    JACC Cardiovasc Imaging; 2022 Nov; 15(11):1941-1943. PubMed ID: 36357135
    [No Abstract]   [Full Text] [Related]  

  • 5. Cardiovascular imaging to guide primary prevention.
    Meah MN; Dweck MR; Newby DE
    Heart; 2020 Aug; 106(16):1267-1275. PubMed ID: 32451365
    [No Abstract]   [Full Text] [Related]  

  • 6. Reducing Cardiovascular Risk in Asymptomatic Patients With Diabetes: Can Stress PET Move the Needle?
    Bourque JM
    JACC Cardiovasc Imaging; 2024 Mar; 17(3):311-313. PubMed ID: 38448130
    [No Abstract]   [Full Text] [Related]  

  • 7. Progress in Cardiovascular Imaging.
    Shaw L; Chandrashekhar Y;
    JACC Cardiovasc Imaging; 2019 Dec; 12(12):2589-2610. PubMed ID: 31806188
    [No Abstract]   [Full Text] [Related]  

  • 8. Cardiovascular biomarkers: added value with an integrated approach?
    Koenig W
    Circulation; 2007 Jul; 116(1):3-5. PubMed ID: 17606853
    [No Abstract]   [Full Text] [Related]  

  • 9. Editor's presentation: Do we really need biomarkers for cardiovascular risk prediction?
    Piepoli MF
    Eur J Prev Cardiol; 2020 Apr; 27(6):563-565. PubMed ID: 32268809
    [No Abstract]   [Full Text] [Related]  

  • 10. The challenge of cardiovascular risk assessment in Chronic Kidney Disease; is there a role for CTA and FFR
    Weir-McCall JR; Sarnak MJ; Nørgaard BL
    J Cardiovasc Comput Tomogr; 2022; 16(5):452-453. PubMed ID: 35717528
    [No Abstract]   [Full Text] [Related]  

  • 11. How far are we from accurate sex-specific risk prediction of cardiovascular disease? One size may not fit all.
    Huang B; Dalakoti M; Lip GYH
    Cardiovasc Res; 2024 Sep; 120(11):1237-1238. PubMed ID: 38862399
    [No Abstract]   [Full Text] [Related]  

  • 12. Current trends in the use of machine learning for diagnostics and/or risk stratification in cardiovascular disease.
    Maurovich-Horvat P
    Cardiovasc Res; 2021 Apr; 117(5):e67-e69. PubMed ID: 33734345
    [No Abstract]   [Full Text] [Related]  

  • 13. Emerging Cardiovascular Risk Factors and Specific Patient Populations at Increased Cardiovascular Risk.
    Katsiki N; Doumas M
    Curr Vasc Pharmacol; 2021; 19(3):241-242. PubMed ID: 33413053
    [No Abstract]   [Full Text] [Related]  

  • 14. [Peripheral Doppler pressure measurement].
    Clemens RK; Amann-Vesti BR; Thalhammer C
    Dtsch Med Wochenschr; 2012 Feb; 137(6):271-3. PubMed ID: 22294113
    [No Abstract]   [Full Text] [Related]  

  • 15. Biomarkers. Screening for C-reactive protein in CVD prediction.
    Peters SA; Visseren FL; Grobbee DE
    Nat Rev Cardiol; 2013 Jan; 10(1):12-4. PubMed ID: 23165068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Future of Cardiovascular Imaging.
    Di Carli MF; Geva T; Davidoff R
    Circulation; 2016 Jun; 133(25):2640-61. PubMed ID: 27324360
    [No Abstract]   [Full Text] [Related]  

  • 17. Synergistic Opportunities in the Interplay Between Cancer Screening and Cardiovascular Disease Risk Assessment: Together We Are Stronger.
    Handy CE; Quispe R; Pinto X; Blaha MJ; Blumenthal RS; Michos ED; Lima JAC; Guallar E; Ryu S; Cho J; Kaye JA; Comin-Colet J; Corbella X; Cainzos-Achirica M
    Circulation; 2018 Aug; 138(7):727-734. PubMed ID: 30359131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imaging in Cardio-Oncology: Where Are We and Where Should We Be Going?
    Steingart RM; Chandrashekhar Y; Marwick TH
    JACC Cardiovasc Imaging; 2018 Aug; 11(8):1209-1211. PubMed ID: 30092977
    [No Abstract]   [Full Text] [Related]  

  • 19. Novel cardiac markers.
    Alder R
    Adv Nurse Pract; 2009 Jun; 17(6):24-7; quiz 28. PubMed ID: 20000180
    [No Abstract]   [Full Text] [Related]  

  • 20. Screening for peripheral arterial disease.
    Grøndal N; Lindholt JS
    Eur J Vasc Endovasc Surg; 2009 Sep; 38(3):314-5. PubMed ID: 19560376
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.